Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease.
Detrusor overactivity
Parkinsonism
Urinary bladder
Urinary incontinence
Urodynamics
Journal
International neurourology journal
ISSN: 2093-4777
Titre abrégé: Int Neurourol J
Pays: Korea (South)
ID NLM: 101534513
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
04
05
2019
accepted:
27
06
2019
entrez:
15
10
2019
pubmed:
15
10
2019
medline:
15
10
2019
Statut:
ppublish
Résumé
To assess the urodynamic findings in patients with Parkinson disease (PD) with overactive bladder symptoms. We performed a retrospective chart review of all PD patients who were seen in an outpatient clinic for lower urinary tract symptoms (LUTS) between 2010 and 2017 in a single-institution. Only patients who complained of overactive bladder (OAB) symptoms and underwent a video-urodynamic study for these symptoms were included. We excluded patients with neurological disorders other than PD and patients with voiding LUTS but without OAB symptoms. We included 42 patients (29 men, 13 women, 74.5±8.1 years old). Seven patients (16.7%) had a postvoid residual (PVR) bladder volume >100 mL and only one reported incomplete bladder emptying. Detrusor overactivity (DO) was found in all 42 patients (100%) and was terminal in 19 (45.2%) and phasic in 22 patients (52.4%). Eighteen patients had detrusor underactivity (DU) (42.3%). Later age of PD diagnosis was the only parameter associated with DU (P=0.02). Patients with bladder outlet obstruction (BOO) were younger than patients without BOO (70.1 years vs. 76.5 years, P=0.004), had later first sensation of bladder filling (173.5 mL vs. 120.3 mL, P=0.02) and first involuntary detrusor contraction (226.4 mL vs. 130.4 mL, P=0.009). DO is almost universal in all patients with PD complaining of OAB symptoms (97.1%). However, a significant percentage of patients also had BOO (36.8%), DU (47%), and increased PVR (16.7%) indicating that neurogenic DO may not be the only cause of OAB symptoms in PD patients.
Identifiants
pubmed: 31607100
pii: inj.1938086.043
doi: 10.5213/inj.1938086.043
pmc: PMC6790817
doi:
Types de publication
Journal Article
Langues
eng
Pagination
211-218Subventions
Organisme : NINDS NIH HHS
ID : U54 NS065736
Pays : United States
Références
Neurourol Urodyn. 2018 Sep;37(7):2220-2225
pubmed: 29635760
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Urol Clin North Am. 2017 Aug;44(3):415-428
pubmed: 28716322
Neurourol Urodyn. 2018 Nov;37(8):2669-2677
pubmed: 29767449
Age Ageing. 1995 Nov;24(6):499-504
pubmed: 8588540
Mov Disord. 2003 Jul;18(7):738-50
pubmed: 12815652
Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(2):144-51
pubmed: 10384979
Neurourol Urodyn. 2014 Jun;33(5):581-6
pubmed: 24844430
J Urol. 1999 May;161(5):1535-40
pubmed: 10210391
Parkinsonism Relat Disord. 2015 Mar;21(3):205-10
pubmed: 25534084
Urology. 2003 Nov;62(5 Suppl 2):3-10
pubmed: 14662401
Int Urogynecol J. 2017 Jun;28(6):805-816
pubmed: 28083714
Urology. 2003 Oct;62(4):651-5
pubmed: 14550436
Neurourol Urodyn. 2017 Nov;36(8):2117-2122
pubmed: 28345779
Neurourol Urodyn. 2002;21(3):261-74
pubmed: 11948720
J Urol. 2006 Mar;175(3 Pt 1):994-8
pubmed: 16469600
Parkinsonism Relat Disord. 2017 Feb;35:8-16
pubmed: 27865667
Dev Neurobiol. 2012 Jun;72(6):918-36
pubmed: 21916020
Toxins (Basel). 2016 Mar 18;8(3):null
pubmed: 26999209
J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):600-6
pubmed: 11606669
Eur Urol. 2017 Sep;72(3):402-407
pubmed: 28400168
BJU Int. 1999 Jul;84(1):14-5
pubmed: 10444116
Urology. 1998 Mar;51(3):408-11
pubmed: 9510344
J Urol. 2009 May;181(5):2209-13
pubmed: 19296974
J Urol. 2000 Nov;164(5):1640-3
pubmed: 11025724
Clin Auton Res. 2018 Feb;28(1):83-101
pubmed: 29124503
Nat Rev Urol. 2017 Feb;14(2):79-89
pubmed: 27958390